These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16508606)

  • 1. [TNF alpha in the physiopathology of psoriasis].
    Rozieres A; Hennino A; Nicolas JF
    Ann Dermatol Venereol; 2006 Feb; 133(2):174-80. PubMed ID: 16508606
    [No Abstract]   [Full Text] [Related]  

  • 2. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.
    Caldarola G; De Simone C; Carbone A; Tulli A; Amerio P; Feliciani C
    Int J Immunopathol Pharmacol; 2009; 22(4):961-6. PubMed ID: 20074459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of severe psoriasis with TNF antagonists. Adalimumab, etanercept and infliximab.
    Mössner R; Reich K
    Curr Probl Dermatol; 2009; 38():107-136. PubMed ID: 19710553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis options abound. Ongoing research on Enbrel and Raptiva supports their use in psoriasis treatment.
    Krueger GG
    Health News; 2004 Jan; 10(1):10-1. PubMed ID: 15002383
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases.
    LaDuca JR; Gaspari AA
    Dermatol Clin; 2001 Oct; 19(4):617-35. PubMed ID: 11705350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases.
    Trent JT; Kerdel FA
    Dermatol Nurs; 2005 Apr; 17(2):97-107. PubMed ID: 15916184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency and safety of etanercept after acute hepatitis induced by infliximab for psoriasis.
    Kluger N; Girard C; Guillot B; Bessis D
    Acta Derm Venereol; 2009; 89(3):332-4. PubMed ID: 19479148
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytokine blocking agents in dermatology.
    Williams JD; Griffiths CE
    Clin Exp Dermatol; 2002 Oct; 27(7):585-90. PubMed ID: 12464154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24.
    Wang F; Smith N; Maier L; Xia W; Hammerberg C; Chubb H; Chen C; Riblett M; Johnston A; Gudjonsson JE; Helfrich Y; Kang S; Fisher GJ; Voorhees JJ
    Br J Dermatol; 2012 Jul; 167(1):92-102. PubMed ID: 22458549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in psoriasis treatment.
    Schön MP
    Lancet; 2005 Oct 15-21; 366(9494):1333-5. PubMed ID: 16226595
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biologics in the treatment of psoriasis].
    Dissemond J; Grabbe S
    MMW Fortschr Med; 2006 Sep; 148(38):42-4. PubMed ID: 17036963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic therapy for psoriasis: the tumor necrosis factor inhibitors infliximab and etanercept.
    Weinberg JM; Saini R
    Cutis; 2003 Jan; 71(1):25-9. PubMed ID: 12553627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of action of etanercept in psoriasis.
    Tan JK; Aphale A; Malaviya R; Sun Y; Gottlieb AB
    J Investig Dermatol Symp Proc; 2007 May; 12(1):38-45. PubMed ID: 17502868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologicals in the treatment of psoriasis.
    Boker A; Kimball AB; Rolz-Cruz G
    Curr Opin Investig Drugs; 2007 Nov; 8(11):939-46. PubMed ID: 17979028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biologic therapy and psoriasis].
    Gamo R; López-Estebaranz JL
    Actas Dermosifiliogr; 2006; 97(1):1-17. PubMed ID: 16540046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-TNF agents and nail psoriasis: a single-center, retrospective, comparative study.
    Kyriakou A; Patsatsi A; Sotiriadis D
    J Dermatolog Treat; 2013 Jun; 24(3):162-8. PubMed ID: 22136334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of TNF-alpha as pain mediator].
    Schaible HG
    Z Rheumatol; 2010 May; 69(3):237-9. PubMed ID: 20309696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly available treatments for psoriatic arthritis and their impact on skin psoriasis.
    Galadari H; Fuchs B; Lebwohl M
    Int J Dermatol; 2003 Mar; 42(3):231-7. PubMed ID: 12653923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept.
    Ducharme E; Weinberg JM
    Expert Opin Biol Ther; 2008 Apr; 8(4):491-502. PubMed ID: 18352852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial.
    Kalb RE; Blauvelt A; Sofen HL; Chevrier M; Amato D; Calabro S; Wang J; Schenkel B; Gottlieb AB
    J Drugs Dermatol; 2013 Aug; 12(8):874-80. PubMed ID: 23986160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.